Kengreal
Active Ingredient(s): CangrelorFDA Approved: * June 22, 2015
Pharm Company: * MEDICINES CO
Category: Blood Thinner (Anticoagulant)
Cangrelor, sold under the brand name Kengreal in the United States, CANREAL in India ( MSN Labs ) and Kengrexal in the European Union) is a P2Y12 inhibitor FDA approved as of June 2015 as an antiplatelet drug[1] for intravenous application. Some P2Y12 inhibitors are used clinically as effective inhibitors of adenosine diphosphate-mediated platelet activation and aggregation.[1] Unlike clopidogrel (Plavix), which is a prodrug, cangrelor is an active drug not req... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.